Willie Quinn is currently the President & CEO at Bolt Biotherapeutics, Inc., a company focused on developing pharmaceutical products for cancer treatment. Prior to Bolt Bio, Quinn held leadership roles in various organizations including A Foundation Building Strength, Sunesis Pharmaceuticals, Midnight Pharma, Neurogastrx, Bullet Biotechnology, and Jazz Pharmaceuticals. Quinn has a strong background in finance, business development, and corporate operations. Willie holds an MBA from Stanford University Graduate School of Business, along with multiple degrees in Japanese literature and language.
Sign up to view 3 direct reports
Get started